Mwachari C W, Cohen C R, Meier A S, Nganga L W, Kimari J N, Odhiambo J A
Center for Respiratory Disease Research, Kenya Medical Research Institute, Nairobi, Kenya.
J Acquir Immune Defic Syndr. 2001 Aug 1;27(4):365-71. doi: 10.1097/00126334-200108010-00006.
To evaluate the WHO (World Health Organization) algorithm for management of respiratory tract infection (RTI) in HIV-1-infected adults and determine risk factors associated with RTI, we enrolled a cohort of 380 HIV-1-seropositive adults prospectively followed for incident RTI at an outpatient clinic in Nairobi, Kenya. RTI was diagnosed when patients presented with history of worsening or persistent cough. Patients were treated with ampicillin, or antituberculosis therapy when clinically indicated, as first-line therapy and with trimethoprim/sulfamethoxazole as second-line therapy. Five hundred ninety-seven episodes of RTI were diagnosed: 177 of pneumonia and 420 of bronchitis. The WHO RTI algorithm was used for 401 (95%) episodes of bronchitis and 151 (85%) episodes of pneumonia (p <.001). Three percent of bronchitis cases versus 32% of pneumonia cases failed to respond to first-or second-line treatment (p <.0001). Being widowed (adjusted odds ratio [OR] = 2.1, 95% confidence interval [CI]: 1.0-4.4), less than 8 years of education (adjusted OR = 2.5, CI: 1.5 - 4.1), and CD4 count < 200 cells/microl (adjusted OR = 2.4, CI: 1.4-3.9) were risk factors for pneumonia. A high percentage of patients (32%) with pneumonia required a change in treatment from that recommended by the WHO guidelines. Randomized trials should be performed to determine more appropriate treatment strategies in HIV-1-infected individuals.
为评估世界卫生组织(WHO)针对HIV-1感染成人呼吸道感染(RTI)的管理算法,并确定与RTI相关的危险因素,我们纳入了380名HIV-1血清阳性成人队列,在肯尼亚内罗毕的一家门诊对其进行前瞻性随访,以观察新发RTI情况。当患者出现咳嗽加重或持续咳嗽病史时诊断为RTI。患者在临床指征明确时,一线治疗采用氨苄西林或抗结核治疗,二线治疗采用甲氧苄啶/磺胺甲恶唑。共诊断出597例RTI发作:177例肺炎和420例支气管炎。401例(95%)支气管炎发作和151例(85%)肺炎发作采用了WHO的RTI算法(p<.001)。3%的支气管炎病例与32%的肺炎病例对一线或二线治疗无反应(p<.0001)。丧偶(调整后的优势比[OR]=2.1,95%置信区间[CI]:1.0 - 4.4)、受教育年限不足8年(调整后的OR = 2.5,CI:1.5 - 4.1)以及CD4细胞计数<200个/微升(调整后的OR = 2.4,CI:1.4 - 3.9)是肺炎的危险因素。高比例(32%)的肺炎患者需要改变WHO指南推荐的治疗方案。应进行随机试验以确定HIV-1感染个体更合适的治疗策略。